MedPath

URASAL GRANULES

URASAL GRANULES

Discontinued
DIN Number

00116866

Drug Class

Human

Market Date

Dec 31, 1951

Company
HC

axxess pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00116866
AIG Number0304181001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
J01XX55 METHENAMINE, COMBINATIONS
Product Specifications
Dosage FormPowder (Effervescent)
Route of AdministrationOral
AHFS Classification08:36.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

METHENAMINEActive
Strength: 0.5 G / 2 TSP
Monograph: METHENAMINE
SODIUM BICARBONATEActive
Strength: 4.6 G / 2 TSP
Monograph: SODIUM BICARBONATE
TARTARIC ACIDActive
Strength: 3.8 G / 2 TSP
Monograph: TARTARIC ACID

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.